Dr. Jane N. Winter, MD

Dr. Winter practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Winter's NPI, 1306864160, was assigned on July 18, 2006. Dr. Winter graduated from Perelman School of Medicine - Philadelphia in 1977. Dr. Winter holds Illinois license 036057716.

Dr. Winter's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Dr. Winter's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Winter is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Winter to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winter practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Winter's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Winter is board certified in hematology by the American Board of Internal Medicine. Dr. Winter is licensed in Illinois.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Winter treats.

CMS data shows 26,620 Medicare services from Dr. Winter across 27 procedure codes in 2024, for 383 Medicare patients. Medicare paid $446,103 for them.

CMS counts 383 Medicare patients who saw Dr. Winter in 2024. The largest group is 65 to 74, with 172 patients. 72% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Winter's median patient age at 73, with 50% women.

In 2024, Dr. Winter wrote 250 Medicare Part D claims for 58 patients. 78% of them were for generic drugs. CMS names the drug for 152 of them, across 4 drugs with 11 or more claims each, at $516,661 in total drug cost. In 2023, CMS named 195 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Winter for performance year 2024, reported through an alternative payment model (APM). Dr. Winter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Winter as offering telehealth.

Dmand AI links 188 papers to Dr. Winter, published from 2006 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Doxorubicin. Dr. Winter has published most often in Blood. Dr. Winter's most frequent co-authors are Leo I. Gordon, MD, Leo Gordon, MD and Govind Bhagat.

Dmand AI links Dr. Winter to 7 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Lymphoma and Hodgkin Disease. Northwestern University sponsors the most, 3.

CMS Open Payments shows 60 general payments to Dr. Winter from 11 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 75% of the total. Merck Sharp & Dohme Corporation paid the most, $18,692. It also lists 1 research payment totaling $86 in 2017.

Dmand AI lists 5 awards for Dr. Winter, most recently America's Top Doctors in 2014.

Dr. Winter graduated from Perelman School of Medicine - Philadelphia in 1977. Dr. Winter is a member of ASCO and ASH.

Dr. Winter is in network with 16 carriers, including HCSC, Cigna and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.